Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Remada Sacubitril and Valsartan Tablet 200 mg:
Remada Sacubitril and Valsartan Tablet 200 mg is a specialized treatment designed for patients with heart failure with reduced ejection fraction. This combination medication targets key pathways to enhance heart function and manage heart failure symptoms effectively.
Uses of Remada Sacubitril and Valsartan Tablet 200 mg:
Remada Sacubitril and Valsartan Tablet 200 mg is used for:
Heart Failure with Reduced Ejection Fraction: Improves heart function and reduces symptoms associated with heart failure, such as shortness of breath, fatigue, and fluid retention.
Reducing Hospitalization Risk: Decreases the risk of hospitalization due to worsening heart failure.
Benefits of Remada Sacubitril and Valsartan Tablet 200 mg:
Remada Sacubitril and Valsartan Tablet 200 mg offers significant benefits for individuals with heart failure. By combining two active ingredients, it provides comprehensive management of heart failure symptoms, improves quality of life, and reduces the likelihood of hospitalization.
Mechanism of Action of Remada Sacubitril and Valsartan Tablet 200 mg:
Sacubitril: Inhibits neprilysin, an enzyme that breaks down natriuretic peptides. This leads to increased levels of these peptides, promoting vasodilation, natriuresis, and diuresis, which help to reduce the strain on the heart.
Valsartan: Acts as an angiotensin II receptor blocker (ARB), preventing angiotensin II from binding to its receptors. This results in vasodilation, reduced blood pressure, and decreased workload on the heart.
Consult your healthcare provider to determine if Remada Sacubitril and Valsartan Tablet 200 mg is suitable for managing your heart failure with reduced ejection fraction